Question 1

What Is VEGF? Vascular Endothelial Growth Factor in Research

Accepted Answer

VEGF, or vascular endothelial growth factor, is a dimeric glycoprotein that stimulates the formation and growth of blood vessels, a process called angiogenesis. Researchers investigate VEGF across a wide range of model systems, from wound healing to tumor biology to retinal vascular research. VEGF-A is the primary isoform documented in published literature and is the form most often referenced when researchers say VEGF without qualification.

Question 2

VEGF Family and Isoforms

Accepted Answer

The VEGF family includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, and placental growth factor (PlGF). Each member has distinct receptor binding preferences and tissue distributions. VEGF-C and VEGF-D, for example, are primarily investigated in lymphangiogenesis models, while VEGF-A is the dominant driver of blood vessel angiogenesis studied in most preclinical tumor and wound models. VEGF-A itself has multiple splice variants: VEGF121, VEGF165, VEGF189, and VEGF206 are the most documented in human research. VEGF165 is the predominant isoform in most tissue types and binds both VEGFR-1 and VEGFR-2 receptors, making it the reference compound in most receptor-binding assays.

Question 3

VEGF Receptors and Signaling

Accepted Answer

VEGF signals through three receptor tyrosine kinases: VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3. VEGFR-2 mediates most of the pro-angiogenic signaling documented in research literature. Receptor binding activates downstream pathways including PI3K/AKT and MAPK/ERK, which regulate endothelial cell proliferation, migration, and tube formation in in vitro assays. Several research peptides have been investigated for their interactions with VEGF pathways. GHK-Cu, for instance, has been studied in models where VEGF expression is modulated by copper-binding peptide activity. These interaction studies appear in peer-reviewed literature examining dermal regeneration and tissue repair models.

Question 4

VEGF in Research Model Applications

Accepted Answer

VEGF is a central endpoint or mechanistic target in several active areas of peptide research. Angiogenesis assays using human umbilical vein endothelial cells (HUVECs) routinely measure VEGF-stimulated tube formation as a standard in vitro readout. Tumor xenograft models often assess VEGF expression as a marker of vascularization. Wound healing models quantify VEGF levels in tissue homogenates alongside other growth factor endpoints. For researchers working with peptide compounds that intersect VEGF pathways, understanding the distinction between isoforms and receptor subtypes is important for experimental design and result interpretation.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research

What Is VEGF? Frequently Asked Questions

Explore Full Research Index